Genome-wide association study of antiphospholipid antibodies

Autoimmune Diseases

Volumn 2013, Issue , 2013, Pages

  Kamboh, M Ilyas ^a   Wang, Xingbin ^a   Kao, Amy H ^b   Barmada, Michael M ^a   Clarke, Ann ^c   Ramsey Goldman, Rosalind ^d   Manzi, Susan ^b   Demirci, F Yesim ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b ALLEGHENY HEALTH NETWORK   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; DNA; HLA ANTIGEN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ARTICLE; CONTROLLED STUDY; GENE IDENTIFICATION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84875647752     PISSN: None     EISSN: 20900430     Source Type: Journal    
DOI: 10.1155/2013/761046     Document Type: Article

References (23)

1. Gharavi A. E., Wilson W. A., Wallace D. J., Hahn B. H., Antphospholipid antibodies. Dubois'Lupus Erythematosus 1997 5th Baltimore, Md, USA Williams & Wilkins 471 491
2. Roubey R. A. S., Update on antiphospholipid antibodies. Current Opinion in Rheumatology 2000 12 5 374 378 2-s2.0-0033839794 10.1097/00002281-200009000- 00004
3. Pierangeli S. S., De Groot P. G., Dlott J., Favaloro E., Harris E. N., Lakos G., Ortel T., Meroni P. L., Otomo K., Pengo V., Tincani A., Wong R., Roubey R., "Criteria" aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, Texas, April 2010. Lupus 2011 20 2 182 190 2-s2.0-79953299697 10.1177/0961203310395055
4. Mackworth-Young C., Chan J., Harris N., High incidence of anticardiolipin antibodies in relatives of patients with systemic lupus erythematosus. Journal of Rheumatology 1987 14 4 723 726 2-s2.0-0023225762 (Pubitemid 17137486)
5. Matthey F., Walshe K., Mackie I. J., Machin S. J., Familial occurrence of the antiphospholipid syndrome. Journal of Clinical Pathology 1989 42 5 495 497 2-s2.0-0024370617 (Pubitemid 19141206)
6. Horita T., Merrill J. T., Genetics of antiphospholipid syndrome. Current rheumatology reports 2004 6 6 458 462 2-s2.0-16644403256
7. Png E., Alisjahbana B., Sahiratmadja E., A genome wide association study of pulmonary tuberculosis susceptibility in Indonesians. BMC Medical Genetics 2012 13 5
8. Miehe S., Bieberstein A., Arnould I., Ihdene O., Rütten H., Strübing C., The phospholipid-binding protein SESTD1 is a novel regulator of the transient receptor potential channels TRPC4 and TRPC5. Journal of Biological Chemistry 2010 285 16 12426 12434 2-s2.0-77951240316 10.1074/jbc.M109.068304
9. Shitao L., Lingyan W., Michael B., Mapping of dynamic innate immunity protein interaction network regulating type I interferon production. Immunity 2011 35 426 440
10. Song Q. L., He X. X., Yang H., Association of TANK gene polymorphism with outcomes of hepatitis B virus infection in a Chinese Han population. Viral Immunology 2012 25 73 78
11. Mosbruger T. L., Duggal P., Goedert J. J., Kirk G. D., Hoots W. K., Tobler L. H., Busch M., Peters M. G., Rosen H. R., Thomas D. L., Thio C. L., Large-scale candidate gene analysis of spontaneous clearance of hepatitis C virus. Journal of Infectious Diseases 2010 201 9 1371 1380 2-s2.0-77950945422 10.1086/651606
12. Pezzolesi M. G., Poznik G. D., Mychaleckyj J. C., Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nature Genetics 2008 40 1092 1097 10.1038/ng.207
13. Maeda S., Araki S. I., Babazono T., Toyoda M., Umezono T., Kawai K., Imanishi M., Uzu T., Watada H., Suzuki D., Kashiwagi A., Iwamoto Y., Kaku K., Kawamori R., Nakamura Y., Replication study for the association between four loci identified by a genome-wide association study on European American subjects with type 1 diabetes and susceptibility to diabetic nephropathy in Japanese subjects with type 2 diabetes. Diabetes 2010 59 8 2075 2079 2-s2.0-77955379980 10.2337/db10-0067
14. Pezzolesi M. G., Poznik G. D., Skupien J., Smiles A. M., Mychaleckyj J. C., Rich S. S., Warram J. H., Krolewski A. S., An intergenic region on chromosome 13q33.3 is associated with the susceptibility to kidney disease in type 1 and 2 diabetes. Kidney International 2011 80 1 105 111 2-s2.0-79958865808 10.1038/ki.2011.64
15. Gigante A., Gasperini M. L., Cianci R., Barbano B., Giannakakis K., Di Donato D., Fuiano G., Amoroso A., Antiphospholipid antibodies and renal involvement. American Journal of Nephrology 2009 30 5 405 412 2-s2.0-69149103389 10.1159/000235941
16. Tektonidou M. G., Renal involvement in the antiphospholipid syndrome (APS)-APS nephropathy. Clinical Reviews in Allergy and Immunology 2009 36 2-3 131 140 2-s2.0-66349127704 10.1007/s12016-008-8112-z
17. Silvarino R., Sant F., Espinosa G., Nephropathy associated with antiphospholipid antibodies in patients with systemic lupus erythematosus. Lupus 2011 20 721 729 10.1177/0961203310397410
18. 2 glycoprotein I is protective against lupus nephritis and renal damage in systemic lupus erythematosus. Journal of Rheumatology 2011 38 3 450 453 2-s2.0-79952415556 10.3899/jrheum.100650
19. Wang L., Yu C., Lu Y., TMEM166, a novel transmembrane protein, regulates cell autophagy and apoptosis. Apoptosis 2007 12 1489 1502 10.1007/s10495-007- 0073-9 (Pubitemid 46988280)
20. Pierdominici M., Vomero M., Barbati C., Role of autophagy in immunity and autoimmunity, with a special focus on systemic lupus erythematosus. FASEB Journal 2012 26 1400 1412 10.1096/fj.11-194175
21. Mũoz L. E., Lauber K., Schiller M., Manfredi A. A., Herrmann M., The role of defective clearance of apoptotic cells in systemic autoimmunity. Nature Reviews Rheumatology 2010 6 5 280 289 2-s2.0-77951971046 10.1038/nrrheum.2010.46
22. Chamorro A. -J., Marcos M., Miron-Canelo J.-A., Val247Leu beta2-glycoprotein-I allelic variant is associated with antiphospholipid syndrome: systemic review and meta-analysis. Autoimmunity Reviews 2012 11 705 712
23. 2-glycoprotein I) which affect phospholipid binding. Human Molecular Genetics 1997 6 2 311 316 2-s2.0-0031054567 10.1093/hmg/6.2.311 (Pubitemid 27078088)